Home / Departments & Hospitals / Pharmacology, Physiology and Microbiology / Pharmacology / Publications
Pharmacology

Publications

NOTICE:
The status of these publications is 08-31-2022 – please find all current publications in our KRIS portal at this link:
https://kris.kl.ac.at/en/organisations/division-pharmacology

  1. 2022

    • Journal Article

      • Lind, J., Hellinger, R., Kudweis, P., Moll, H.P., Gattringer, J., Thell, K., Edtmayer, S., Gruber, C.W., Stoiber-Sakaguchi, D. & Kollmann, K., 2022. The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma. Biomedicine & Pharmacotherapy, 153.

      • Witalisz-Siepracka, A., Klein, K., Zdársky, B. & Stoiber-Sakaguchi, D., 2022. The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance. Frontiers in Immunology, 13.

    • Conference Paper

      • Edtmayer, S., Witalisz-Siepracka, A., Zdársky, B., Eder, T., Poli, V., Grebien, F. & Stoiber-Sakaguchi, D., 2022. Poster: P399: UNRAVELING THE TUMOR SUPPRESSIVE ROLE OF STAT3Β IN ACUTE MYELOID LEUKEMIA. In HemaSphere.

      • Zdársky, B., Witalisz-Siepracka, A., Boigenzahn, S., Fiedler, K. & Stoiber-Sakaguchi, D., 2022. Poster: P483: STAT3 DRIVES IMMUNE EVASION OF MLL-AF9-DRIVEN ACUTE MYELOID LEUKEMIA. In HemaSphere.

  2. 2021

    • Journal Article

      • Breitenecker, K., Homolya, M., Luca, A.C., Lang, V., Trenk, C., Petroczi, G., Mohrherr, J., Horvath, J., Moritsch, S., Haas, L., Kurnaeva, M., Eferl, R., Stoiber-Sakaguchi, D., Moriggl, R., Bilban, M., Obenauf, A.C., Ferran, C., Dome, B., Laszlo, V., Gyorffy, B., Dezso, K., Moldvay, J., Casanova, E. & Moll, H.P., 2021. Down-regulation of A20 promotes immune escape of lung adenocarcinomas. Science translational medicine, 13(601), S.eabc3911 [pii].

      • Grandits, A.Michael, Nguyen, C.Huu, Schlerka, A., Hackl, H., Sill, H., Etzler, J., Heyes, E., Stoiber-Sakaguchi, D., Grebien, F., Heller, G. & Wieser, R., 2021. Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness. Leukemia.

      • Kerschan-Schindl, K., Föger-Samwald, U., Gleiss, A., Kudlacek, S., Wallwitz, J. & Pietschmann, P., 2021. Circulating bioactive sclerostin levels in an Austrian population-based cohort. Wiener klinische Wochenschrift.

      • Klein, K., Stoiber-Sakaguchi, D., Sexl, V. & Witalisz-Siepracka, A., 2021. Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?. Cancers, 13(11), S.2611.

      • Klein, K., Witalisz-Siepracka, A., Gotthardt, D., Agerer, B., Locker, F., Grausenburger, R., Knab, V.Maria, Bergthaler, A. & Sexl, V., 2021. T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo. Frontiers in immunology, 12, S.650977.

      • Liang, H.-C., Costanza, M., Prutsch, N., Zimmerman, M.W., Gurnhofer, E., Montes-Mojarro, I.A., Abraham, B.J., Prokoph, N., Stoiber, S., Tangermann, S., Lobello, C., Oppelt, J., Anagnostopoulos, I., Hielscher, T., Pervez, S., Klapper, W., Zammarchi, F., Silva, D.-A., K. Garcia, C., Baker, D., Janz, M., Schleussner, N., Fend, F., Pospisilova, S., Janikova, A., Wallwitz, J., Stoiber-Sakaguchi, D., Simonitsch-Klupp, I., Cerroni, L., Pileri, S., de Leval, L., Sibon, D., Fataccioli, V., Gaulard, P., Assaf, C., Knörr, F., Damm-Welk, C., Woessmann, W., Turner, S.D., A. Look, T., Mathas, S., Kenner, L. & Merkel, O., 2021. Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma. Nature Communications, 12(1).

      • Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Fan, F., Zwickl-Traxler, E., Stoiber-Sakaguchi, D., Bakiri, L., Wagner, E.F., Sattler, M., Pecherstorfer, M. & Podar, K., 2021. Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs Inducing Synergistic Anti-Myeloma Activity. Blood, 138(Supplement 1), S.2644-2644.

      • Sharif, O., Brunner, J.Stefanie, Korosec, A., Martins, R., Jais, A., Snijder, B., Vogel, A., Caldera, M., Hladik, A., Lakovits, K., Saluzzo, S., Boehm, B., Gorki, A.-D., Mesteri, I., Lindroos-Christensen, J., Tillmann, K., Stoiber-Sakaguchi, D., Menche, J., Schabbauer, G., Bilban, M., Superti-Furga, G., Esterbauer, H. & Knapp, S., 2021. Beneficial Metabolic Effects of TREM2 in Obesity are Uncoupled from its Expression on Macrophages. Diabetes.

      • Wallwitz, J., Aigner, P. & Stoiber-Sakaguchi, D., 2021. Tumor suppressors in acute myeloid leukemia. Leukemia & lymphoma, S.1-11.

      • Zdársky, B., Edtmayer, S., Witalisz-Siepracka, A. & Stoiber-Sakaguchi, D., 2021. The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia. Biomedicines, 9(8).

    • Conference Paper

      • Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Zwickl-Traxler, E., Fan, F., Stoiber-Sakaguchi, D., Bakiri, L., Wagner, E., Sattler, M., Pecherstorfer, M. & Podar, K., 2021. Presentation: OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity. In 18th International Myeloma Workshop. 08.-11.09.2021. Vienna, Austria, S. S19-S20.

  3. 2020

    • Journal Article

      • Stoiber-Sakaguchi, D. & Assinger, A., 2020. Platelet-Leukocyte Interplay in Cancer Development and Progression. Cells, 9(4).

      • Wakolbinger, R., Muschitz, C., Wallwitz, J., Bodlaj, G., Feichtinger, X., Schanda, J.E., Resch, H., Baierl, A. & Pietschmann, P., 2020. Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis. Wiener klinische Wochenschrift, 132(1-2), S.19-26.

  4. 2019

    • Journal Article

      • Aigner, P., Mizutani, T., Horvath, J., Eder, T., Heber, S., Lind, K., Just, V., Moll, H.P., Yeroslaviz, A., Fischer, M.J.M., Kenner, L., Gyorffy, B., Sill, H., Grebien, F., Moriggl, R., Casanova, E. & Stoiber-Sakaguchi, D., 2019. STAT3beta is a tumor suppressor in acute myeloid leukemia. Blood advances, 3, S.1989-2002.

      • Gluexam, T., Grandits, A.M., Schlerka, A., Nguyen, C.Huu, Etzler, J., Finkes, T., Fuchs, M., Scheid, C., Heller, G., Hackl, H., Harrer, N., Sill, H., Koller, E., Stoiber-Sakaguchi, D., Sommergruber, W. & Wieser, R., 2019. CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia. International journal of molecular sciences, 20.

      • Wallwitz, J., Aigner, P., Gadermaier, E., Bauer, E., Casanova, E., Bauer, A. & Stoiber-Sakaguchi, D., 2019. Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritis. PloS one, 14, S.e0220935.

  5. 2015

    • Journal Article

      • Grabner, B., Schramek, D., Mueller, K.M., Moll, H.P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., Stiedl, P., Nivarthi, H., Bogner, E., Gruber, W., Mohr, T., Zwick, R.Harun, Kenner, L., Poli, V., Aberger, F., Stoiber-Sakaguchi, D., Egger, G., Esterbauer, H., Zuber, J., Moriggl, R., Eferl, R., Gyorffy, B., Penninger, J.M., Popper, H. & Casanova, E., 2015. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nature Communications, 6, S.6285.

Events

  1. 11 Apr

    STUDENT TALK Psychology

    11. April 2023, 18:00
    Instagram Channel - Live Q&A
  2. 14 Apr

    Austria Model WHO

    14. April 2023, 10:00 - 16. April 2023, 17:00
    Karl Landsteiner Privatuniversität für Gesundheitswissenschaften, Dr.-Karl-Dorrek-Straße 30, 3500 Krems an der Donau
  3. 19 Apr

    KL Lunchtime Seminar: How do we know in which direction our eyes are pointing

    19. April 2023, 12:00 - 13:00
    Karl Landsteiner Privatuniversität, Skylounge